These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 8330753)
21. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest. Brambrink AM; Martin LJ; Hanley DF; Becker KJ; Koehler RC; Traystman RJ J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600 [TBL] [Abstract][Full Text] [Related]
22. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Gill R; Nordholm L; Lodge D Brain Res; 1992 May; 580(1-2):35-43. PubMed ID: 1504814 [TBL] [Abstract][Full Text] [Related]
23. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists. Maj J; Rogóz Z; Skuza G; Jaros T Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504 [TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled. Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist. Tortella FC; Britton P; Williams A; Lu XC; Newman AH J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930 [TBL] [Abstract][Full Text] [Related]
26. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Yang Y; Li Q; Shuaib A Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442 [TBL] [Abstract][Full Text] [Related]
27. Hippocampal N-methyl-D-aspartate receptor-mediated encoding and retrieval processes in spatial working memory: delay-interposed radial maze performance in rats. Yoshihara T; Ichitani Y Neuroscience; 2004; 129(1):1-10. PubMed ID: 15489023 [TBL] [Abstract][Full Text] [Related]
28. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging. Busch E; Gyngell ML; Eis M; Hoehn-Berlage M; Hossmann KA J Cereb Blood Flow Metab; 1996 Nov; 16(6):1090-9. PubMed ID: 8898680 [TBL] [Abstract][Full Text] [Related]
29. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Bernert H; Turski L Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559 [TBL] [Abstract][Full Text] [Related]
30. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia]. Liu XG; Feng YP Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015 [TBL] [Abstract][Full Text] [Related]
31. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats. Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454 [TBL] [Abstract][Full Text] [Related]
32. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Smith SE; Meldrum BS Stroke; 1995 Jan; 26(1):117-21; discussion 121-2. PubMed ID: 7839380 [TBL] [Abstract][Full Text] [Related]
33. NBQX reduces threshold of protein synthesis inhibition in focal ischaemia in rats. Kohno K; Mies G; Djuricic B; Hossmann KA Neuroreport; 1994 Nov; 5(17):2342-4. PubMed ID: 7881056 [TBL] [Abstract][Full Text] [Related]
34. Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. Smith SE; Lekieffre D; Sowinski P; Meldrum BS Neuroreport; 1993 Sep; 4(12):1339-42. PubMed ID: 7903166 [TBL] [Abstract][Full Text] [Related]
35. Delayed treatment with 5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione, a glycine site N-methyl-D-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats. Sarhan S; Wettstein JG; Maynard KI Neurosci Lett; 2003 Aug; 347(3):147-50. PubMed ID: 12875907 [TBL] [Abstract][Full Text] [Related]
36. The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats. Niu HX; Wang JZ; Wang DL; Miao JJ; Li H; Liu ZG; Yuan X; Liu W; Zhou JR Cell Mol Neurobiol; 2018 Mar; 38(2):459-466. PubMed ID: 28401316 [TBL] [Abstract][Full Text] [Related]
37. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat. Smith SE; Meldrum BS Funct Neurol; 1993; 8(1):43-8. PubMed ID: 8330753 [TBL] [Abstract][Full Text] [Related]
38. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339 [TBL] [Abstract][Full Text] [Related]
39. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia. DeGraba TJ; Ostrow P; Hanson S; Grotta JC J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322 [TBL] [Abstract][Full Text] [Related]
40. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. Graham SH; Chen J; Lan JQ; Simon RP J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]